Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbamazepine and erythroid arrest.

C A Medberry, A A Pappas, B H Ackerman

    Drug Intelligence & Clinical Pharmacy
    |May 1, 1987
    PubMed
    Summary

    Carbamazepine can cause late-onset anemia due to isolated erythroid toxicity. Discontinuing the drug quickly resolved the patient's anemia, highlighting the need for regular patient monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ethylene glycol toxicity: the role of serum glycolic acid in hemodialysis.

    Journal of toxicology. Clinical toxicology·2002
    Same author

    Interinstitutional variation in glycohemoglobin monitoring and glycemic control of diabetic patients.

    Archives of pathology & laboratory medicine·2001
    Same author

    Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial.

    Journal of the American Academy of Dermatology·2000
    Same author

    A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.

    Annals of clinical and laboratory science·2000
    Same author

    Amoxicillin-clavulanic acid: additions and corrections.

    Mayo Clinic proceedings·2000
    Same author

    Toxicology: past, present, and future.

    Annals of clinical and laboratory science·1999

    Area of Science:

    • Hematology
    • Pharmacology
    • Clinical Toxicology

    Background:

    • Carbamazepine is a widely used anticonvulsant and mood-stabilizing medication.
    • Hematologic toxicities are known adverse effects of carbamazepine therapy.
    • These toxicities typically manifest earlier in the course of treatment.

    Observation:

    • A case report details a patient experiencing anemia with isolated erythroid toxicity after prolonged carbamazepine use.
    • The patient's anemia resolved rapidly upon cessation of the drug.
    • This specific toxicity profile and late onset are unusual for carbamazepine.

    Findings:

    • Isolated erythroid toxicity is an uncommon adverse effect of carbamazepine.
    • The onset of carbamazepine-induced hematologic toxicity can be delayed.
    • Discontinuation of carbamazepine leads to prompt resolution of this specific anemia.

    Implications:

    • Clinicians should be vigilant for late-onset hematologic toxicities, including isolated erythroid toxicity, in patients taking carbamazepine.
    • Regular monitoring of complete blood counts is crucial for patients on chronic carbamazepine therapy.
    • Prompt recognition and drug withdrawal can effectively manage carbamazepine-induced anemia.

    Related Experiment Videos